Sequencing Controls Improve Confidence in NGS Patient Results

A conversation with Keith Cannon, Director Product Management, Horizon Discovery Ltd.
Conceptual Circuit Intelligence

Mainstreaming Precision Oncology

Sponsored content brought to you by   What if every patient’s oncologist or lab testing personnel had access to an online digital encyclopedia of cancer mutations,...
Clinical OMICs Keynote Webinar lead image

Newborn Genomic Screening: In Sickness and In Health

In this inaugural Clinical OMICs Keynote webinar, we are proud to host two renowned leaders in the field of genomic medicine, Drs Stephen Kingsmore and Robert Green, who will discuss their pioneering work in the field of newborn genome sequencing and analysis.
Oxford Nanopore eBook cover

Clinical Research in a Real-Time Sequencing Age

Oxford Nanopore’s DNA/RNA sequencing technology delivers ultra-long reads (up to 2 Mb), enabling rapid and comprehensive analysis of variants. With devices scalable from portable to benchtop, nanopore sequencing offers a cost-effective solution to the challenges faced by traditional sequencing platforms.

The Next Era in Pathway Proteomics: Turnkey Targeted Quantitation Workflows

REGISTER NOW Broadcast Date: October 1, 2019 Time: 8:00 am PT, 11:00 am ET, 17:00 CET Accurate monitoring of cell signaling pathway proteins, particularly tyrosine phosphorylation (pTyr)...

Rethinking Rx-Dx Codevelopment

Codevelopment is an intermittent and uncertain process. Adopting an agnostic approach to the challenges associated with platform and method selection provide added degrees of freedom for strategic development and selection of the most appropriate clinical trial assay.

LeukoVantage: A Quest/QIAGEN Partnership Providing Clinical Insights Into Myeloid Malignancies

In this webinar, we will describe Quest’s LeukoVantage assay, an NGS test designed specifically for detecting clinically relevant variants in myeloid malignancies, and its partnership with N-of-One, a QIAGEN company, for expert interpretation.

Rise of Genomics in Clinical Trials

The challenges of incorporating NGS into clinical trials is being addressed through the adoption of robust technology solutions.
Protein (ubiquitin) molecule (cartoon model). Stylized image.

In-Cell Protein Footprinting: A New Tool for Proteome-Wide Structural Biology

VIEW NOW Broadcast Date: June 26, 2019 Time: 8:00 am PT, 11:00 am ET, 17:00 CET Protein structure must be studied in its native cellular environment, otherwise,...

Cancer Gene Variant Detection Using a Pre-Optimized Sample to Report Workflow

REGISTER NOW Broadcast Date: September 12, 2019 Time: 8:00 am PT, 11:00 am ET, 17:00 CET BRCA1/BRCA2 genes represent the best examples for our current understanding of...
Scroll Up